| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Entasis Therapeutics Holdings Inc. | Chief Scientific Officer | Common Stock | 0 | $2.20 | 11 Jul 2022 | Direct | |
| Entasis Therapeutics Holdings Inc. | Chief Scientific Officer | Stock Option (right to buy) | 0 | 11 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ETTX | Entasis Therapeutics Holdings Inc. | 07 Jul 2022 | 6 | -$87.1K | 4 | Chief Scientific Officer | 11 Jul 2022, 16:09 |
| ETTX | Entasis Therapeutics Holdings Inc. | 18 Jan 2022 | 1 | $0 | 4 | Chief Scientific Officer | 19 Jan 2022, 15:05 |
| ETTX | Entasis Therapeutics Holdings Inc. | 02 Nov 2021 | 1 | -$10.8K | 4 | Chief Scientific Officer | 03 Nov 2021, 16:02 |
| [ETTX] | Entasis Therapeutics Holdings Inc. | 19 Oct 2021 | 2 | -$12K | 4 | Chief Scientific Officer | 20 Oct 2021, 16:08 |
| ETTX | Entasis Therapeutics Holdings Inc. | 16 Jul 2021 | 8 | $0 | 4 | Chief Scientific Officer | 15 Feb 2022, 15:05 |